天麻素联合异丙嗪治疗颈性眩晕的临床观察

Clinical observation on treating cervical vertigo with gastrodin plus promethazine

目的:分析天麻素联合异丙嗪治疗颈性眩晕的临床效果。方法:研究阶段为2017年9月-2018年1月,共纳入研究对象64例,均为颈性眩晕患者,随机分为两组。两组在相同基础治疗上,对照组采用天麻素治疗,观察组采用天麻素联合异丙嗪治疗,比较两组临床效果。结果:对照组总有效26例(81.25%),观察组总有效30例(93.75%),差异具有统计学意义,P <0.05。对照组眩晕、自主神经症状、前庭功能受损、耳蜗症状消失时间均长于观察组,差异具有统计学意义,P <0.05。两组均未出现严重不良反应。结论:天麻素联合异丙嗪联合应用于颈性眩晕患者的治疗疗效良好,起效快,无明显不良反应,值得临床推广与应用。

Objective:To analyze the clinical efficacy of gastrodia plus promethazine on cervical vertigo.Methods:64 cases were randomly divided into two groups.Two groups were given the same basic treatment.The control group was treated with gastrodia.The observation group was treated with gastrodia plus promethazine.The clinical efficacy in two groups was compared.Results:The efficiency was 81.25%(26 cases)in the control group,and 93.75%(30 cases)in the observation group,with a statistically significant difference,P<0.05.Vertigo,autonomic nerve symptoms,vestibular dysfunction and the disappearance time of cochlea symptoms in the control group were longer than those in the observation group,with statistically significant differences,P<0.05.There were no serious adverse reactions in two group.Conclusion:The gastrodia and promethazine show a good effect,with quick effects and no obvious adverse reactions,and is worthy of clinical popularization and application.